跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 29,503 条关于
“I-SPY2”
全部
29,503
临床试验
22,615
药物
615
机构
98
资讯
6,175
上个月
Patient-Derived Breast Cancer Organoids Validate I-SPY2 Biomarkers and Predict Treatment Response
去年
Study Reveals HR+/MP-H2 Breast Cancers Share Key Features with Triple-Negative Disease, Opening New Treatment Pathways
9个月前
Circulating Tumor DNA Emerges as Powerful Prognostic Tool for Triple-Negative Breast Cancer Recurrence Risk
去年
Datopotamab Deruxtecan Plus Durvalumab Shows Promise in Early-Stage Breast Cancer Subtypes
去年
DetermaIO Gene Test Predicts Atezolizumab Benefit in Triple-Negative Breast Cancer
5年前
I-SPY COVID Trial: Adaptive Platform Design Accelerates COVID-19 Therapeutic Discovery
4个月前
Liquid Biopsy Blood Tests Predict Breast Cancer Immunotherapy Response in Vanderbilt Study
2年前
I-SPY 2.2 Trial Revolutionizes Breast Cancer Treatment with Patient-Centered Design
去年
I-SPY 2.2 Trial Design Shows Promise in Identifying Less Toxic Breast Cancer Therapies
去年
Olaparib Provides Long-Term Survival Benefit in BRCA2-Mutated Ovarian Cancer
第 1 页,共 618 页
上一页
下一页